Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
Navigating Presbyopia Conversations with Patients in Practice
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Demographic factors influence uptake of glaucoma screening in first-degree relatives following a familial diagnosis
  • Glaucoma

Demographic factors influence uptake of glaucoma screening in first-degree relatives following a familial diagnosis

Kelsey Moroz

Primary open-angle glaucoma (POAG) has a genetic component, thus first-degree relatives of individuals with POAG should be screened for glaucoma. Researchers sought to assess glaucoma screening uptake among first-degree relatives of patients with glaucoma in the community- (n=261) versus hospital-based (n=196) settings. They found that certain factors were associated with glaucoma screening uptake in first-degree relatives.

Individuals were invited for screening and underwent eye examinations, and those with suspected glaucoma underwent further confirmatory testing. Mean patient age was 70 years (range, 41-96 years).

Among the first-degree relatives invited, significantly more individuals in the hospital-based group underwent screening compared with the community-based group (64.5% vs 30.1%, respectively; P<.001). The researchers found that the following characteristics made individuals more likely to participate in screening:

  • Women (odds ratio [OR], 1.64; 95% CI, 1.14-2.38)
  • Age older than 45 years (OR, 2.06; 95% CI, 1.32-3.21)
  • Those who were related to an originating patient with blindness (OR, 1.69; 95% CI, 1.13-2.54)
  • Those with secondary education or higher (OR, 2.49; 95% CI, 1.48-4.18)

Among first-degree relatives screened, glaucoma was suspected in 19.2% and confirmed in 8.3%.

The study is limited by its non-randomized study design. In addition, the study took place in Chanthaburi, Thailand, where knowledge and disease information “are not comprehensive for all individuals in the area, potentially leading to incomplete and insufficient communication to the public,” the authors noted.

“The study shows that the hospital-based group had a significantly higher screening uptake than the community-based group, reflecting that information from the ophthalmic nurses is more effective and well-received than that from general nurses and village health volunteers,” the authors concluded.

Reference

Nitikarun P, Kongsap P. Comparative analysis of glaucoma screening uptake among first-degree relatives after community-based and hospital-based approaches. Clin Ophthalmol. 2024;18:1563-1573. doi:10.2147/OPTH.S459318

Share

Related Content

  • Glaucoma

US registry tracks interventional glaucoma treatment patterns

  • Conference Roundup

How to have meaningful conversations with patients about holistic management of their glaucoma

  • Conference Roundup

Advances in glaucoma: a case-based session

  • Glaucoma

Proposal calls for low-level disinfection of tonometers

  • Glaucoma

Neighborhood socioeconomic disadvantage not linked to glaucoma outcomes in veterans

  • Glaucoma

Large wearable study examines physical activity and sleep in adults with glaucoma

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon